Have a personal or library account? Click to login
The Impact of Pneumonia on the Course and Outcome in Patients with Seasonal Influzenza Cover

The Impact of Pneumonia on the Course and Outcome in Patients with Seasonal Influzenza

Open Access
|Oct 2020

References

  1. 1. Thompson WW, Moore MR, Weintraub E Cheng P-Y, Jin X, Bridges CB, MD, Bresee JS, Shay DK. Estimating Influenza-Associated Deaths in the United StatesAm J Public Health. 2009; 99(2): 225–230.
  2. 2. Fraaij PL, Houmes RJ, Geukers VM, Gesink-van der Veer BJ, Kneyber MC, Tibboel D. Acute respiratory distress syndrome’ (ARDS) as a serious complication of influenza. Ned Tijdschr Geneeskd. 2010; 154: 1640.
  3. 3. Corrin B. Diffuse alveolar damage: the pathological basis of adult respiratory distress syndrome. In: Corrin B, editor. Pathology of the lungs. London: Churchill Livingston: 2000. 121–143.
  4. 4. Mitchell ML, Melisse SB, Gordon RB, Rob F, Teri JF, Frederick GH, Rita H, Stephen EL, Thomas RM, Michael SN, et al. Clinical issues and research in respiratory failure from severe acute respiratory syndrome. Am J Respir Crit Care Med 2005; 171: 518–526.10.1164/rccm.200405-621WS
  5. 5. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. INER Working Group on Influenza. Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico. N Engl J Med. 2009; 361(7): 680–689.10.1056/NEJMoa0904252
  6. 6. Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O. Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. J Clin Virol. 2016; 79: 68–73.10.1016/j.jcv.2016.04.005
  7. 7. Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, Arroyo-Anduiza CI, Gaytán-Martínez JE, Manjarrez-Téllez B, Ochoa-Carrera LA, Sandoval-Ramírez JL.Risk factors associated with mortality in patients infected with influenza A/ H1N1 in Mexico. BMC Res Notes. 2015; 11; 8: 432. doi: 10.1186/s13104-015-1349-8.10.1186/s13104-015-1349-8
  8. 8. Liu L, Zhang RF, Lu HZ et al. Sixty-two severe and critical patients with 2009 influenza A (H1N1) in Shanghai, China. Chin Med J (Engl). 2011 Jun; 124(11): 1662–6.
  9. 9. Woo HC, Yun SK, Doo SJ et al. Outcome of pandemic H1N1 pneumonia: clinical and radiological findings for severity assessment. Korean J Intern Med. 2011; 26: 160–167.10.3904/kjim.2011.26.2.160
  10. 10. Campigotto A, Mubareka S. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts. Expert Rev Anti Infect Ther. 2015; 13(1): 55–68.10.1586/14787210.2015.981156
  11. 11. Cawcutt K, Kalil AC. Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care. 2017; 23(5): 385–390.10.1097/MCC.0000000000000435
  12. 12. Martin-Loeches I, van Someren Gréve F, Schultz MJ. Bacterial pneumonia as an influenza complication. Curr Opin Infect Dis. 2017; 30(2): 201–207.10.1097/QCO.0000000000000347
  13. 13. Reed C, Chaves SS, Perez A, D’Mello T, Daily Kirley P, Aragon D, Meek JI, Farley MM, Ryan P, Lynfield R, Morin CA, Hancock EB, Bennett NM, Zansky SM, Thomas A, Lindegren ML, Schaffner W, Finelli L. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis. 2014; 59(2): 166-174.10.1093/cid/ciu285
  14. 14. Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003; 28(3): 225–232.10.1016/S1386-6532(03)00119-7
  15. 15. Cunha BA, Corbett M, Mickail N.Influenza A presenting as viral encephalitis in an adult.Heart Lung. 2011; 41(3): 308–309.10.1016/j.hrtlng.2011.06.00721831435
  16. 16. Funaki T, Shoji K, Yotani N, Katsuta T, Miyazaki O, Nosaka S, Masaki H, Saitoh A. The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection. BMC Infect Dis. 2013;13:516. doi: 10.1186/1471-2334-13-516.10.1186/1471-2334-13-516422841024180416
  17. 17. Kumar S, Havens PL, Chusid MJ, Willoughby RE Jr, Simpson P, Henrickson KJ. Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J. 2010;29(7):591–594.10.1097/INF.0b013e3181d73e32
  18. 18. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, Wang Y, Wang W, Kang J, Liu P. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis. 2010; 10: 145. doi: 10.1186/1471-2334-10-145.10.1186/1471-2334-10-145289000520513239
  19. 19. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, Chuang JH, Kuo HS, Chang SC: Predictors and Outcomes of Respiratory Failure among Hospitalized Pneumonia Patients with 2009 H1N1 Influenza in Taiwan. J Infect.2010; 60(2): 168–17410.1016/j.jinf.2009.12.01220036689
  20. 20. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E, Lipkin WI: Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009; 4 (12): e 8540 doi 10.1371/journal.pone.0008540.10.1371/journal.pone.0008540279519520046873
  21. 21. Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis. 2016; 63(3): 300-309.10.1093/cid/ciw300494602127161775
  22. 22. Teng F, Liu X, Guo SB, et al. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. J Infect Chemother. 2019; 25(2): 129–136.10.1016/j.jiac.2018.10.01430448361
  23. 23. Witczak A, Prystupa A, Kurys-Denis E, Borys M, Czuczwar M, Niemcewicz M, Kocik J, Michalak A, Pietrzak A, Chodorowska G, Krupski W, Mosiewicz J, Tomasiewicz K. Acute respiratory distress syndrome (ARDS) complicating influenza A/H1N1v infection--a clinical approach. Ann Agric Environ Med. 2013;20(4):820-822.
  24. 24. Töpfer L, Menk M, Weber-Carstens S, Spies C, Wernecke KD, Uhrig A, Lojewski C, Jörres A, Deja M. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014; 29(3): 340–346.10.1016/j.jcrc.2013.12.01324508203
  25. 25. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007; 150: 306–310.10.1016/j.jpeds.2006.11.05417307552
  26. 26. Khandaker G, Zurynski Y, Buttery J, Marshall H, Richmond PC, Dale RC, Royle J, Gold M, Snelling T, Whitehead B, Jones C, Heron L, McCaskill M, Macartney K, Elliott EJ, Booy R. Neurologic complications of influenza A(H1N1) pdm09:surveillance in 6 pediatric hospitals. Neurology. 2012; 79(14): 1474–1481.10.1212/WNL.0b013e31826d5ea7409882322993280
  27. 27. Ekstrand JJ, Herbener A, Rawlings J, et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol. 2010; 68(5): 762–766.10.1002/ana.2218420865762
  28. 28. Watanabe T. Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr. 2013 Jan; 172(1): 15–22.10.1007/s00431-012-1854-x23064728
  29. 29. Cruz-Lagunas A, Jiménez-Alvarez L, Ramírez G, Mendoza-Milla C, García-Sancho MC, Avila-Moreno F, Zamudio P, Urrea F, Ortiz-Quintero B, Campos-Toscuento VL, Morán J, Barrera AA, Martínez-Briseño D, Fernández-Plata R, Sierra-Vargas MP, Muñoz-Perea C, Illescas-Flores S, Bautista E, Suratt BT, Pérez-Padilla JR, Zuñiga J. Obesity and pro-inflammatory mediators are associated with acute kidney injury in patients with A/H1N1 influenza and acute respiratory distress syndrome. Exp Mol Pathol. 2014; 97(3): 453–45710.1016/j.yexmp.2014.10.00625305354
  30. 30. Vallejos A. The role of nephrology in the influenza A (H1N1) pandemic. Nefrologia. 2009; 29(6): 576–581.
  31. 31. Cillóniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, Gabarrús A, Marcos MA, Cordoba J, Mensa J, Torres A. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012; 65(3): 223–230.10.1016/j.jinf.2012.04.009713240222543245
  32. 32. Möricke A, Zimmermann M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010 Feb; 24(2): 265–84.10.1038/leu.2009.25720010625
  33. 33. Lauten M, Möricke A, Beier R, et al. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica. 2012 Jul; 97(7): 1048–56.10.3324/haematol.2011.047613339667722271901
  34. 34. Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the children’s cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children’s Oncology Group Report. Leukemia. 2010 Feb; 24(2): 285–97.10.1038/leu.2009.262290613920016531
DOI: https://doi.org/10.2478/prilozi-2020-0034 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Language: English
Page range: 63 - 70
Published on: Oct 2, 2020
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 Marija Cvetanovska, Zvonko Milenovic, Krsto Grozdanovski, Ilir Demiri, Katerina Spasovska, Vlatko Cvetanovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.